Depigmentation

Revision as of 18:30, 3 June 2015 by Kiran Singh (talk | contribs) (→‎Overview)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Depigmentation

Articles

Most recent articles on Depigmentation

Most cited articles on Depigmentation

Review articles on Depigmentation

Articles on Depigmentation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Depigmentation

Images of Depigmentation

Photos of Depigmentation

Podcasts & MP3s on Depigmentation

Videos on Depigmentation

Evidence Based Medicine

Cochrane Collaboration on Depigmentation

Bandolier on Depigmentation

TRIP on Depigmentation

Clinical Trials

Ongoing Trials on Depigmentation at Clinical Trials.gov

Trial results on Depigmentation

Clinical Trials on Depigmentation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Depigmentation

NICE Guidance on Depigmentation

NHS PRODIGY Guidance

FDA on Depigmentation

CDC on Depigmentation

Books

Books on Depigmentation

News

Depigmentation in the news

Be alerted to news on Depigmentation

News trends on Depigmentation

Commentary

Blogs on Depigmentation

Definitions

Definitions of Depigmentation

Patient Resources / Community

Patient resources on Depigmentation

Discussion groups on Depigmentation

Patient Handouts on Depigmentation

Directions to Hospitals Treating Depigmentation

Risk calculators and risk factors for Depigmentation

Healthcare Provider Resources

Symptoms of Depigmentation

Causes & Risk Factors for Depigmentation

Diagnostic studies for Depigmentation

Treatment of Depigmentation

Continuing Medical Education (CME)

CME Programs on Depigmentation

International

Depigmentation en Espanol

Depigmentation en Francais

Business

Depigmentation in the Marketplace

Patents on Depigmentation

Experimental / Informatics

List of terms related to Depigmentation

Overview

The definition of depigmentation is the lightening of the skin, or loss of pigment. Depigmentation of the skin can be caused by a number of local and systemic conditions. The pigment loss can be partial (injury to the skin) or complete (caused by vitiligo). It can be temporary (from tinea versicolor) or permanent (from albinism).

Most commonly, depigmentation of the skin is linked to people who suffer with vitiligo. These individuals, if they so decided to complete the lightening process, would apply a topical cream containing the organic compound monobenzone to remove the remaining pigment. The brand drug incorporating 20% monobenzone is Benoquin, made by ICN.

Increasingly, people who are not afflicted with the disease vitiligo have been experimenting with lower concentrations of self compounded mono creams in the hope of lightening their skin tone evenly.

An alternate method of lightening is to use the chemical mequinol over an extended period of time. Both monobenzone and mequinol produce dramatic whitening of the skin, but react very differently.

For stubborn pigmented lesions the Q-switched ruby laser, cryotherapy or TCA peels can be used to ensure the skin remains pigment free.

Mequinol leaves the skin looking extremely pale however, tanning is still possible. Monobenzone applied topically completely removes pigment in the long term and vigorous sun-safety needs to be adhered to for life.

People using monobenzone without previously having vitiligo do so because standard products containing hydroquinone or other lightening agents are not effective for their skin and due to price and active ingredient strength. However, monobenzone is not recommended for skin conditions other than vitiligo.


Template:WH Template:WS